Evidence for multiple allograft rejection mechanisms within the same experimental system

Current Opinion in Organ Transplantation

Volumn 10, Issue 1, 2005, Pages 20-27

  Bumgardner, Ginny L ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Allograft rejection; Donor associated factors; Genetic factors; Immune repertoire

Indexed keywords

ALLOANTIBODY; CD4 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD8 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; OKT 4; OKT 8; TRANSFORMING GROWTH FACTOR BETA;

ALLOIMMUNITY; ANTIGEN PRESENTING CELL; CELL TRANSPLANTATION; CLINICAL GENETICS; EXPERIMENTAL DESIGN; GRAFT REJECTION; HEART TRANSPLANTATION; HEREDITY; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INDIVIDUALIZATION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LIVER TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL DECISION MAKING; MICROENVIRONMENT; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT MONITORING; RECIPIENT; REVIEW; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 17344366569     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Pearson TC, Alexander DZ, Winn KJ, et al. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994; 57:1701-1706.
2. Turka LA, Linsley PS, Lin H, et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992; 89:11102-11107.
3. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61:4-9.
4. Kirk AD, Harlan DM, Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94:8789-8794.
5. + T cells. J Immunol 1999; 163:2358-2362.
6. + cells that independently initiate rejection of allogeneic hepatocytes in mice. Hepatology 2000; 32:1018-1028.
7. Le Moine A, Goldman M. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am J Transplant 2003; 3:101-106.
8. + T cells: there's more to it than MHC restriction. Am J Transplant 2003; 3:107-115.
9. Bumgardner GL, Orosz CG. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 2000; 174:260-279.
10. Bumgardner GL, Orosz CG. Transplantation and cytokines. Semin Liver Dis 1999; 19:189-204.
11. Dresske B, Lin X, Huang D, et al. Spontaneous tolerance: experience with the rat liver transplant model. Hum Immunol 2002; 63:853.
12. Kataoka M, Margenthaler JA, Ku G, et al. 'Infectious tolerance' develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants. Surgery 2003; 134:227-234.
13. Asakura H, Ku G, Kataoka M, Flye MW. Regulatory cells develop after the spontaneous acceptance of rat liver allografts. Surgery 2004; 136:532-536.
14. + T calls can trigger allograft rejection. J Immunol 2000; 165:1111-1118.
15. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104:1715.
16. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 2001; 167:4821-4827.
17. Bickerstaff AA, Wang JJ, Xia D, Orosz CG. Allograft acceptance despite differential strain-specific induction of TGF-beta/IL-10-mediated immunoregulation. Am J Transplant 2002; 2:819-827.
18. + cells and CD40-CD40 ligand interactions. J Immunol 2001; 166:3248-3255.
19. Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 2003; 162:509-519.
20. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145-155.
21. Hutchinson IV, Pravica V, Hajeer A, Sinnott PJ. Identification of high and low responders to allografts. Rev Immunogenet 1999; 1:323-333.
22. Coudert JD, Coureau C, Guery JC. Preventing NK cell activation by donor dendritic cells enhances allospecific CD4 T cell priming and promotes Th type 2 responses to transplantation antigens. J Immunol 2002; 169:2979-2987.
23. Foucras G, Coudert JD, Coureau C, Guery JC. Dendritic cells prime in vivo alloreactive CD4 T lymphocytes toward type 2 cytokine- and TGF-beta-producing cells in the absence of CD8 T cell activation. J Immunol 2000; 165:4994-5003.
24. Bumgardner GL, Gao D, Li J, et al. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 2000; 70:1771-1780.
25. + T cells in allograft acceptance induced by DST and CD40/CD154 costimulatory blockade. Am J Transplant 2004; 4:1061-1070.
26. Valujskikh A, Pantenburg B, Heeger PS. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant 2002; 2:501-509.
27. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887-1895.
28. Adams AB, Pearson TC, Larsen CP. Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev 2003; 196:147-160.
29. Chen Y, Heeger PS, Valujskikh A. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J Immunol 2004; 172:5456-5466.
30. Niederkom JY. The immune privilege of corneal grafts. J Leukoc Biol 2003; 74:167-171.
31. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8:582-587.
32. Sacks S, Zhou W. The effect of locally synthesised complement on acute renal allograft rejection. J Mol Med 2003; 81:404-410. [Epub ahead of print]
33. Schroppel B, Zhang N, Chen P, et al. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol 2004; 15:1853-1861.
34. Li K, Patel H, Farrar CA, et al. Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J Am Soc Nephrol 2004; 15:2414-2422.
35. Kawamoto S, Yalcindag A, Laouini D, et al. The anaphylatoxin C3a down-regulates the Th2 response to epicutaneously introduced antigen. J Clin Invest 2004; 114:399-407.
36. Kreisel D, Krupnick AS, Balsara KR, et al. Mouse vascular endothelium activates CD8+ T lymphocytes in a B7-dependent fashion. J Immunol 2002; 169:6154-6161.
37. Sumgardner GL, Li J, Heininger M, et al. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 1998; 65:47-52.
38. Bickerstaff AA, Wang JJ, Pelletier RP, Orosz CG. The graft helps to define the character of the alloimmune response. Transpl Immunol 2002; 9: 137-141.
39. + cell subsets and different mechanisms. Transplantation 2004; 78:660-667.
40. Lunsford KE, Gao D, Eiring AM, et al. Evidence for tissue directed immune responses: analysis of CD4-dependent and CD8-dependent alloimmunity. Transplantation (in press).
41. Bumgardner GL, Gao D, Li J, et al. MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host. Transplantation 2002; 74:855-864.
42. Baker MS, Chen X, Rotramel A, et al. Proinflammatory cytokines induce NF-kappaB-dependent/NO-independent chemokine gene expression in MIN6 beta cells. J Surg Res 2003; 110:295-303.
43. Zhang N, Schroppel B, Chen D, et al. Adenovirus transduction induces expression of multiple chemokines and chemokine receptors in murine beta cells and pancreatic islets. Am J Transplant 2003; 3:1230-1241.
44. Chen MC, Proost P, Gysemans C, et al. Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia 2001; 44: 325-332.
45. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, et al. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 2001; 167: 399-406.
46. Wang H, Gao X, Fukumoto S, et al. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol 1999; 181:361-370.
47. Park JW, Gruys ME, McCormick K, et al. Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). J Immunol 2001; 166:3763-3770.
48. Abdi R, Means TK, Ito T, et al. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. J Immunol 2004; 172:767-775.
49. He C, Schenk S, Zhang Q, et al. Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol 2004; 172:240-247.
50. Jones TR, Adams AB, Shirasugi NJ, et al. Allogeneic parenchymal and hematopoietic tissues differ in their ability to induce deletion of donor-reactive T cells. Am J Transplant 2003; 3:1520-1530.